Business context and reporting period
Maris-Tech Ltd. filed this Form 20-F for the fiscal year ended December 31, 2021; it is an annual report, not a standalone fourth-quarter filing. The Israel-based company develops and sells miniature video, audio and communications systems for professional, defense, homeland-security, drone and civilian markets. Financial statements are prepared under U.S. GAAP in U.S. dollars.
Key financial metrics
| Metric | 2021 | 2020 |
|---|---|---|
| Revenue | $2.076 million | $987,883 |
| Gross profit / gross margin | $969,308 / 46.7% | $487,187 / 49.3% |
| Operating expenses | $1.542 million | $878,138 |
| Operating loss / margin | $572,901 / 27.6% | $390,951 / 39.6% |
| Net loss / net margin | $824,224 / 39.7% | $640,343 / 64.8% |
| Cash used in operating activities | $875,002 | $418,490 |
| Cash used in investing activities | $29,424 | $33,543 |
| Cash provided by financing activities | $899,181 | $455,360 |
Revenue rose 110%, driven by increased sales to existing and new customers, mainly in Israel. Cost of revenue increased 121%, so gross margin declined by about 2.6 percentage points. R&D expense decreased 10% to $706,021; sales and marketing rose to $241,114 and general and administrative expense to $595,074, reflecting hiring, marketing activity and IPO-related professional costs. Net loss increased 29%; financial expense was $251,323, including a $77,551 warrant fair-value remeasurement.
Balance sheet, liquidity and debt
At December 31, 2021, cash and cash equivalents were $785 (2020: $20,524); the cash-flow statement reports $49,126 including restricted deposits. Working capital deficit was approximately $994,850, compared with $841,901 a year earlier. Total assets were $2.039 million and total liabilities $4.419 million, leaving shareholders’ capital deficiency of $2.380 million. Trade receivables were $571,482 and inventory $391,484.
Year-end bank credit and current maturities of bank loans totaled $410,324, with a further $744,769 of long-term bank loans. Long-term shareholder loans were $1.088 million; short-term liabilities due to shareholders were $296,459. In February 2022, after year-end, the company repaid bank and Yaad liabilities of approximately $1.2 million and released related collateral and certain personal guarantees. It completed its IPO in February 2022, receiving approximately $15 million net proceeds ($17.8 million gross), materially changing its post-year-end liquidity position.
Material changes versus the prior comparable period
- Revenue more than doubled, while operating loss and net loss widened as selling, administrative and financing costs increased.
- Operating cash outflow more than doubled, mainly reflecting the net loss and increases in receivables and inventory, partly offset by higher payables and other current liabilities.
- Trade receivables rose from $127,538 to $571,482 and inventory from $251,067 to $391,484.
- Working capital deficit increased by approximately $153,000. The February 2022 IPO and debt repayments occurred after the reporting date and are not included in year-end cash.
Outlook, commentary, risks and unusual items
- Management expected year-end cash together with IPO proceeds to fund operations for at least the next 12 months. The company has incurred losses and negative operating cash flows since inception and cautions that additional funding may be needed if plans or results change.
- Backlog was approximately $608,000 on January 1, 2022 and $1.202 million on April 28, 2022; management expected nearly all of the latter to be delivered and recognized as revenue by the end of 2022. Backlog is not guaranteed revenue and orders may be delayed or cancelled.
- Management plans continued R&D investment and expansion, particularly in North America, alongside marketing, sales and distributor efforts. Several products remained in development; stated launch dates and commercialization expectations are forward-looking and uncertain.
- COVID-19 did not negatively affect 2021 financial results according to the company, but pandemic-related component shortages increased lead times and costs and could continue to affect deliveries and profitability. The filing also identifies geopolitical, supplier, manufacturing, competition, market-acceptance, currency and regulatory risks.
- As of December 31, 2021, management reported material weaknesses in financial-reporting controls: insufficient appropriately trained U.S. GAAP/SEC reporting staff and inadequate segregation of duties. Disclosure controls were deemed ineffective. Remediation included hiring a qualified CFO, seeking more finance personnel and developing an accounting-policy manual; effectiveness was not yet established.
- The company had received approximately $285,204 in IIA grants, including accumulated interest, and reported approximately $277,903 of royalties remaining as of April 28, 2022. Royalties and approval requirements may apply to sales, overseas manufacturing or transfer of supported know-how.
- The 2021 financial statements are audited and received an unqualified opinion. The auditor did not attest to internal-control effectiveness.
Important facts for investors to verify
- Reconcile the $785 year-end cash balance and $49,126 cash-flow figure, which includes restricted deposits, with the IPO’s approximately $15 million net proceeds and subsequent debt repayments.
- Confirm the post-IPO debt balances, repayment details and remaining obligations, including shareholder loans and any related-party amounts.
- Track conversion of backlog into recognized revenue, collections of the increased receivables, and inventory usage or obsolescence.
- Assess whether gross margins recover and whether operating expenses and cash burn remain proportionate to revenue growth.
- Monitor remediation and independent validation of the disclosed material weaknesses and ineffective disclosure controls.
- Verify product-development timelines, customer concentration and the continuing effects of component availability, IIA obligations and foreign-exchange movements.